The cost of cure: Examining objective and subjective financial toxicity in head and neck cancer survivors

Background Little is documented regarding objective financial metrics and their impact on subjective financial toxicity in head and neck cancer (HNC) survivors. Methods In a cross‐sectional analysis, 71 survivors with available claims data for HNC‐specific out‐of‐pocket expenses (OOPE) completed a s...

Full description

Saved in:
Bibliographic Details
Published in:Head & neck 2021-10, Vol.43 (10), p.3062-3075
Main Authors: Baddour, Khalil, Fadel, Mark, Zhao, Meng, Corcoran, Michael, Owoc, Maryanna S., Thomas, Teresa H., Sabik, Lindsay M., Nilsen, Marci L., Ferris, Robert L., Mady, Leila J.
Format: Article
Language:English
Subjects:
Cost of Illness
Cross-Sectional Studies
financial toxicity
Head & neck cancer
head and neck cancer
Head and Neck Neoplasms - therapy
Health Expenditures
health services
Humans
multidisciplinary research
out‐of‐pocket expenses
patient‐reported outcomes
Survival
Survivors
survivorship
Toxicity
treatment costs
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Little is documented regarding objective financial metrics and their impact on subjective financial toxicity in head and neck cancer (HNC) survivors. Methods In a cross‐sectional analysis, 71 survivors with available claims data for HNC‐specific out‐of‐pocket expenses (OOPE) completed a survey including patient‐reported, subjective financial toxicity outcome tools: the Comprehensive Score for financial Toxicity (COST) and the Financial Distress Questionnaire (FDQ). Results Worse COST scores were significantly associated with lower earnings at survey administration (coefficient = 3.79; 95% CI 2.63–4.95; p 
ISSN:1043-3074
1097-0347
DOI:10.1002/hed.26801